Last Price
4.38
Today's Change
-0.15 (3.31%)
Day's Change
4.37 - 4.59
Trading Volume
257,317
Market Cap
285 Million
Shares Outstanding
65 Million
Avg Volume
429,742
Avg Price (50 Days)
4.20
Avg Price (200 Days)
3.87
PE Ratio
7.68
EPS
0.57
Earnings Announcement
27-Mar-2025
Previous Close
4.53
Open
4.58
Day's Range
4.372 - 4.59
Year Range
2.0 - 6.35
Trading Volume
257,317
1 Day Change
-3.31%
5 Day Change
-3.74%
1 Month Change
7.88%
3 Month Change
33.13%
6 Month Change
-8.56%
Ytd Change
0.69%
1 Year Change
9.50%
3 Year Change
-39.50%
5 Year Change
-39.50%
10 Year Change
-39.50%
Max Change
-39.50%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.